place

Melinta Therapeutics

2000 establishments in ConnecticutCompanies based in Morris County, New JerseyCompanies that filed for Chapter 11 bankruptcy in 2019Morristown, New JerseyPharmaceutical companies based in New Jersey
Pharmaceutical companies established in 2000Pharmaceutical companies of the United States

Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey.In mid-2011, Sanofi entered into a global research collaboration and licensing option with the company to develop and commercialize novel antibiotics. It was renamed Melinta Therapeutics in 2013.One of its products, delafloxacin (Baxdela), a fluoroquinolone antibiotic acquired from Wakunaga Pharmaceutical in 2006, was approved by the FDA in 2017.As of 2016, the company was also developing radezolid, a next-generation oxazolidinone for bacterial acne.Melinta shredded off its discovery research team in late 2018. It also moved its headquarters from New Haven to Morristown, New Jersey in early 2019. On December 27, 2019, Melinta Therapeutics filed for Chapter 11 bankruptcy protection.On April 2020, it was transferred to affiliates of its creditor Deerfield Management.

Excerpt from the Wikipedia article Melinta Therapeutics (License: CC BY-SA 3.0, Authors).

Melinta Therapeutics
East Hanover Avenue, Morris Township

Geographical coordinates (GPS) Address Nearby Places
placeShow on map

Wikipedia: Melinta TherapeuticsContinue reading on Wikipedia

Geographical coordinates (GPS)

Latitude Longitude
N 40.80164 ° E -74.4586 °
placeShow on map

Address

Frelinghuysen Arboretum

East Hanover Avenue
07927 Morris Township
New Jersey, United States
mapOpen on Google Maps

Share experience

Nearby Places